NFE2L2 and colorectal carcinoma: Taken together, these results revealed a novel role of PRDX1 in triggering CRC progression by inhibiting ferroptosis through enhancing NRF2 stability by binding to CUL3, highlighting a pivotal molecular chaperone activity of PRDX1.